Electronic decision support for deprescribing (MedSafer tool) for Deprescribing

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Deprescribing+2 MoreElectronic decision support for deprescribing (MedSafer tool) - Other
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test the feasibility of using an electronic tool to generate real-time reports on patients' drug use, displayed to clinicians in the electronic medical record.

Eligible Conditions
  • Deprescribing
  • Adverse Drug Reactions (ADRs)
  • Overmedication

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
MyPath Web-Based Informational and Decision Support Tool
1
Physician Education about Gabapentinoid Prescription
1
Medication reduction

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 1 year

1 year
Cost savings
30-days after the prescriber receives a deprescribing report.
Proportion of patients with one or more PIM (potentially inappropriate medication) reduced or stopped
Examined at 30-days following each intervention cycle (3 cycles)
Sustainability; quality of life; sleep quality; falls; transfer to acute hospital; hip fractures; and delirium

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
MyPath Web-Based Informational and Decision Support Tool
1
Physician Education about Gabapentinoid Prescription
1
Medication reduction

Trial Design

2 Treatment Groups

Control: Baseline (no MedSafer)
1 of 2
Intervention: MedSafer
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: Electronic decision support for deprescribing (MedSafer tool) · No Placebo Group · N/A

Intervention: MedSafer
Other
Experimental Group · 1 Intervention: Electronic decision support for deprescribing (MedSafer tool) · Intervention Types: Other
Control: Baseline (no MedSafer)NoIntervention Group · 1 Intervention: Control: Baseline (no MedSafer) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

OMNI Health CareUNKNOWN
MED e-care Healthcare SolutionsUNKNOWN
Centre for Aging and Brain Health InnovationOTHER
13 Previous Clinical Trials
1,634 Total Patients Enrolled
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
399 Previous Clinical Trials
125,224 Total Patients Enrolled
1 Trials studying Deprescribing
1,000 Patients Enrolled for Deprescribing
Emily McDonald, MDCMPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Age 65+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top